Fig. 3From: Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastasesLong-term survival in the BR-NAC and CR-US groups. a Recurrence-free survival. b Overall survival. Survival curves were calculated from the date of chemotherapy initiation in the BR-NAC group and from the date of hepatic resection in the CR-US groupBack to article page